The largest database of trusted experimental protocols

Rifampin

Manufactured by Thermo Fisher Scientific
Sourced in United Kingdom, United States

Rifampin is a laboratory product used in various research and analytical applications. It is a chemical compound that serves as a key reagent for specific assays and experiments. The core function of Rifampin is to provide a standardized and reliable chemical component for researchers and scientists to utilize in their work.

Automatically generated - may contain errors

31 protocols using rifampin

1

Antimicrobial Evaluation of Biofilms

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tryptic soy broth (TSB) was purchased from MilliporeSigma (Burlington, MA), Petri dishes, agar, and general supplies/reagents from Fisher Scientific (Hampton, NH), and brain heart infusion (BHI) broth from Research Products International (Mt Prospect, IL). CDC biofilm reactors and titanium (Ti) coupons were purchased from Biosurface Technologies (Bozeman, MT). Levofloxacin was acquired from Chem-Impex International (Wood Dale, IL) and rifampin from ThermoFisher Scientific (Waltham, MA).
+ Open protocol
+ Expand
2

Comprehensive Reagent Sourcing for Diverse Biochemical Analyses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chemicals and reagents used in this study were obtained as follows: Sigma-Aldrich (St. Louis, MO, USA) for bull serum albumin (BSA), Evans blue, Triton X-100, Tween-20, 4′,6-diamidino-2-phenylindole (DAPI), isopropyl-β-d-thiogalactoside (IPTG), Coomassie brilliant blue G 250, rifampin, kanamycin, gentamicin, and methyllycaconitine citrate (MLA); Thermo Fisher Scientific (Waltham, MA, USA) for fluorescent α-bungarotoxin conjugates; Gibco (Thermo Fisher Scientific, Inc., Waltham, MA, USA) for penicillin G, streptomycin, glutamine, and pyruvate; Abcam (Cambridge, UK) for antibodies against SLURP1, α7 nAChR or β-actin; Proteintech (Proteintech Group, Chicago, IL, USA) for enzyme-linked immunosorbent assay (ELISA) kits. The rest reagents were purchased from Beyotime Institute of Biotechnology, Shanghai, China.
+ Open protocol
+ Expand
3

Lactobacillus delbrueckii subsp. bulgaricus Growth Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
L. delbrueckii subsp. bulgaricus LBB.B5 was obtained from the LBB Culture Collection (LB Bulgaricum Plc, Sofia, Bulgaria). A spontaneous rifampin-resistant mutant of L. delbrueckii subsp. bulgaricus LBB.B5 (LBB.B5-R) was used for this study by selecting a single-colony isolate grown on deMan, Rogosa, and Sharpe agar (MRS) (BD, Franklin Lakes, NJ) containing 50 μg/ml rifampin (Thermo Fisher Scientific, Waltham, MA). When indicated, the strain was incubated in ultrahigh temperature (UHT)-processed 2% reduced fat milk (Gossner Foods, Logan, UT). To measure cell growth in response to exogenous nucleobases, purine (adenine and guanine) or pyrimidine (uracil) bases were added to the milk to a final concentration of 20 μg/ml. Bacterial cultures were serially diluted, plated onto MRS agar containing 50 μg/ml rifampin, and incubated at 37°C for 2 days prior to colony enumeration.
Equal quantities of L. delbrueckii subsp. bulgaricus LBB.B5-R (approximately 106 CFU/ml) were inoculated into either MRS (n = 3) or milk (n = 6) and incubated at 37°C without aeration for 24 h. After 16 h at 37°C, three of the cultures in milk were transferred to 4°C and incubated for the subsequent 5 days. For all cultures, pH was periodically measured with the S20 SevenEasy (Mettler-Toledo LLC, Columbus, OH), and numbers of viable cells were estimated on MRS plates containing 50 μg/ml RIF.
+ Open protocol
+ Expand
4

Antibiotic Susceptibility Testing of Lactobacillus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Double-layer disc diffusion was used to determine the susceptibility to metronidazole (5μg), clindamycin (2μg), penicillin (2μg) and amoxicillin (10μg; Davies Diagnostics, South Africa), as described previously [58 (link)]. These experiments were performed in duplicate. For rifampicin and rifabutin (Sigma-Aldrich, USA), minimal inhibitory concentrations (MICs) were determined using two-fold serial dilutions according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) 2019 guidelines, with concentrations ranging from 5–0.00488μg/mL for rifabutin and 25–0.024μg/mL for rifampicin. MICs below the lowest or above the highest concentration tested were assigned a MIC half of the lowest or twice the highest concentration tested, respectively. Experiments were performed in duplicate. For a subset of Lactobacillus strains (n = 20), broader antibiotic susceptibility profiles were determined using Sensititre GPALL1F plates (including ampicillin, cefoxitin, chloramphenicol, ciprofloxacin, clindamycin, daptomycin, erythromycin, gentamicin, levofloxacin, linezolid, moxifloxacin, nitrofurantoin, oxacillin, penicillin, quinupristin/dalfopristin, rifampin, streptomycin, tetracycline, tigecycline, trimethoprim/sulamethoxazole and vancomycin; Thermo Fisher Scientific Inc., USA), according to the manufacturer’s instructions.
+ Open protocol
+ Expand
5

Determining Antibiotic IC50 in M. tuberculosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the IC50 of each antibiotic, M. tuberculosis strains were grown to an OD580 of ~0.7 and diluted into fresh medium to an OD580 of 0.02. Diluted cultures were transferred to a 96-well microtiter plate containing triplicate two-fold serial dilutions of antibiotic. Cell-wall-active antibiotics (vancomycin and meropenem) were supplemented at all concentrations with 5 µg/ml potassium clavulanate to inhibit the intrinsic β-lactamase activity of M. tuberculosis. After 5 days of incubation at 37°C, growth in each well was measured by OD580. IC50 values were interpolated from a nonlinear least-squares fit of log2-transformed OD580 measurements. Data are representative of two independent experiments. Antibiotics were purchased from Sigma-Aldrich (clavulanate, ethionamide, meropenem, rifampin, and vancomycin) or Thermo-Fisher Scientific (ciprofloxacin, ethambutol, isoniazid, norfloxacin, and streptomycin).
+ Open protocol
+ Expand
6

Antibiotic Resistance Profiling of S. aureus

Check if the same lab product or an alternative is used in the 5 most similar protocols
The phenotypic pattern of antibiotic resistance of S. aureus bacteria was investigated using the disk diffusion method on Mueller–Hinton agar (Merck, Germany).13 (link) Principles of the Clinical Laboratory Standard Institute (CLSI) were used for this purpose.14 Diverse kinds of antibiotic agents including aminoglycosides (amikacin (30 µg/disk) and gentamicin (10 µg/disk)), fluoroquinolones (levofloxacin (5 µg/disk) and ciprofloxacin (5 µg/disk)), lincosamides (clindamycin (2 µg/disk)), macrolides (erythromycin (15 µg/disk) and azithromycin (15 µg/disk)), penicillins (penicillin (10 µg/disk)), tetracyclines (doxycycline (30 µg/disk) and tetracycline (30 µg/disk)), phenicols (chloramphenicol (30 µg/disk)), folate pathway inhibitors (trimethoprimsulfamethoxazole (25 µg/disk)), and ansamycins (rifampin (5 µg/disk)) were used for this goal (Oxoid, UK). The method was completed using the protocol characterized previously.14
S. aureus (ATCC 43300 and ATCC 29213) was used as the quality control organism in antimicrobial susceptibility determination.
+ Open protocol
+ Expand
7

Antibiotic Susceptibility of Listeria

Check if the same lab product or an alternative is used in the 5 most similar protocols
All strains collected were analyzed by the KB method using breakpoints recommended by the National Committee for Clinical Laboratory Standards (Clinical and Laboratory Standards Institute, 2014 ) for Staphylococcus, except for ampicillin and penicillin G where specific Listeria breakpoints are defined (M45-A2 Vol. 30 No. 18) (Supplementary Table S3). In total, 16 antibiotic agents, including those used to treat human listeriosis, were tested by the KB method as follows: ampicillin (AMP; 10 μg), chloramphenicol (C; 30 μg), erythromycin (E; 15 μg), gentamicin (CN; 10 μg), kanamycin (K; 30 μg), rifampin (RD; 5 μg), doxycycline (DO, 30 μg), penicillin (P, 10 U), tetracycline (TE; 30 μg), vancomycin (VA; 30 μg), sulfamethoxazole with trimethoprim (SXT; 23.75/1.25 μg), sulbactam/ampicillin (SAM; 10/10 μg), meropenem (MEM; 10 μg), linezolid (LZD, 30 μg), and amoxycillin/clavulanic acid (AMC; 10 μg) (Oxoid, Basingstoke, United Kingdom). Staphylococcus aureus ATCC 25923 and Escherichia coli ATCC 25922 were used as quality control strains. Zones of inhibition were measured with precision calipers to the nearest 0.01 mm. Isolates exhibiting resistance to at least three classes of the antimicrobial agents tested, were considered multidrug-resistant strains.
+ Open protocol
+ Expand
8

Antibiotic Resistance Profiling of S. epidermidis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patterns of antimicrobial resistance of the S. epidermidis strains were studied using the Kirby-Bauer method. A simple disk diffusion technique on the Mueller-Hinton agar (Merck, Germany) medium was used for this purpose. susceptibility of S. epidermidis isolates was tested against several types of antibiotic agents including penicillin (10 μg/disk), cefazolin (30 μg/disk), clindamycin (2 μg/disk), mupirocin (30 μg/disk), azithromycin (15 μg/disk), erythromycin (15 μg/disk), tetracycline (30 μg/disk), ciprofloxacin (5 μg/disk), trimethoprim-sulfamethoxazole (25 μg/disk), nitrofurantoin (300 μg/disk), and rifampin (5 μg/disk) (Oxoid, UK). The instructions of the Clinical and Laboratory Standards Institute were used for this purpose [46 ]. The plates containing the disks were allowed to stand for at least 30 min before incubated at 37 °C for 24 h. The diameter of the zone of inhibition produced by each antibiotic disc was measured and interpreted using the CLSI zone diameter interpretative standards [46 ]. S. epidermidis ATCC 12228 was used as a quality control organism in antimicrobial susceptibility determination.
+ Open protocol
+ Expand
9

Antimicrobial Susceptibility of S. aureus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolates were identified as S. aureus by Gram stain, catalase production, mannitol fermentation, coagulase and DNase production, and resistance to cefoxitin. Antimicrobial susceptibility tests were performed by disc diffusion assay and interpreted according to the Clinical Laboratory Standards Institute [17 ] for the following antimicrobials: gentamicin, chloramphenicol, ciprofloxacin, clindamycin, erythromycin, linezolid, rifampin, tetracycline and trimethoprim/sulfamethoxazole (Oxoid Ltd, Basingstoke, UK). Multidrug resistance (MDR) was defined as resistance to three or more classes of non-β-lactam antimicrobials.
+ Open protocol
+ Expand
10

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Standard antibiotic susceptibility testing by the disc diffusion test was performed for cefoxitin (30 μg), fusidic acid (10 μg), erythromycin (15 μg), clindamycin (2 μg), trimethoprim/sulphamethoxazole (25 μg), gentamicin (10 μg), norfloxacin (10 μg), ciprofloxacin (5 μg), rifampin (5 μg) and vancomycin (5 μg) (all antibiotic discs from Oxoid, Basingstoke, Hampshire, England), with a 0.5 McFarland bacterial suspension in 0.85 % NaCl on Mueller–Hinton agar (Oxoid). After 16–20 h of incubation at 36 °C, the zone diameters were measured and each isolate was evaluated according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints (http://www.eucast.org, accessed 2015-03-20).
Standard minimum inhibitory concentration (MIC) determination with the Etest (bioMérieux) was performed for vancomycin and teicoplanin on Mueller–Hinton agar (Oxoid) with a bacterial suspension adjusted to 0.5 McFarland in 0.85 % NaCl. The results were determined after 24 h of incubation at 36 °C, and, again, each isolate was evaluated according to EUCAST breakpoints.
Isolates resistant to ≥3 antibiotic groups tested were considered multidrug-resistant (MDR).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!